Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice
Dipak Sarnobat, R. Charlotte Moffett, Victor A. Gault, et al.
Peptides (2019) Vol. 125, pp. 170205-170205
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Glucose-dependent insulinotropic polypeptide (GIP)
Timo D. Müller, Alice E. Adriaenssens, Bo Ahrén, et al.
Molecular Metabolism (2025) Vol. 95, pp. 102118-102118
Open Access | Times Cited: 3
Proglucagon-Derived Peptides as Therapeutics
Ryan A. Lafferty, Finbarr O’Harte, Nigel Irwin, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 51
Taurine rescues pancreatic β‐cell stress by stimulating α‐cell transdifferentiation
Dipak Sarnobat, R. Charlotte Moffett, Jinfang Ma, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 646-662
Open Access | Times Cited: 13
GABA and insulin but not nicotinamide augment α- to β-cell transdifferentiation in insulin-deficient diabetic mice
Dipak Sarnobat, R. Charlotte Moffett, Peter R. Flatt, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115019-115019
Open Access | Times Cited: 18
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
Zhihong Yao, Wang Chen, Zhu Qianqian, et al.
Peptides (2023) Vol. 162, pp. 170955-170955
Closed Access | Times Cited: 10
The role of gut–islet axis in pancreatic islet function and glucose homeostasis
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
The Beneficial Impact of a Novel Pancreatic Polypeptide Analogue on Islet Cell Lineage
Wuyun Zhu, Neil Tanday, Peter R. Flatt, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4215-4215
Open Access
Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation
Neil Tanday, Nigel Irwin, R. Charlotte Moffett, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 12, pp. 2468-2478
Open Access | Times Cited: 24
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A. Lafferty, Neil Tanday, R. Charlotte Moffett, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Neil Tanday, Andrei I. Tarasov, R. Charlotte Moffett, et al.
Diabetes Obesity and Metabolism (2023) Vol. 26, Iss. 1, pp. 16-31
Open Access | Times Cited: 9
Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiation
Dipak Sarnobat, R. Charlotte Moffett, Neil Tanday, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114216-114216
Open Access | Times Cited: 18
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2353-2363
Open Access | Times Cited: 11
Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations
Dipak Sarnobat, R. Charlotte Moffett, Peter R. Flatt, et al.
Journal of Endocrinological Investigation (2021) Vol. 45, Iss. 1, pp. 95-103
Open Access | Times Cited: 13
Not the second fiddle: α cell development, identity, and function in health and diabetes
Elliott P. Brooks, Lori Sussel
Journal of Endocrinology (2023) Vol. 258, Iss. 2
Open Access | Times Cited: 5
Activation of Gs signaling in mouse enteroendocrine K cells greatly improves obesity- and diabetes-related metabolic deficits
Antwi‐Boasiako Oteng, Liu Liu, Yinghong Cui, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 24
Open Access | Times Cited: 1
Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1Cre/+;Rosa26‐eYFP mice
Neil Tanday, R. Charlotte Moffett, Victor A. Gault, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 3
Open Access | Times Cited: 9
Increased NKX6.1 expression and decreased ARX expression in alpha cells accompany reduced beta-cell volume in human subjects
Yukari Fujita, Junji Kozawa, Kenji Fukui, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells
Shruti Mohan, Ryan A. Lafferty, Neil Tanday, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261608-e0261608
Open Access | Times Cited: 7
Classical and non-classical islet peptides in the control of β-cell function
Dawood Khan, R. Charlotte Moffett, Peter R. Flatt, et al.
Peptides (2021) Vol. 150, pp. 170715-170715
Open Access | Times Cited: 7
Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders
Sarah Craig, Nigel Irwin, Victor A. Gault
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14
Open Access | Times Cited: 6
The glucagon receptor antagonist desHis1Pro4Glu9-glucagon(Lys12PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasia
Ryan A. Lafferty, Neil Tanday, Vaibhav Dubey, et al.
Molecular and Cellular Endocrinology (2023) Vol. 570, pp. 111932-111932
Open Access | Times Cited: 2
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
Ananyaa Sridhar, Dawood Khan, Peter R. Flatt, et al.
Peptides (2023) Vol. 169, pp. 171093-171093
Open Access | Times Cited: 2
Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, et al.
Peptides (2022) Vol. 152, pp. 170772-170772
Open Access | Times Cited: 3
Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists
Elena Jiménez-Martí, Gema Hurtado-Genovés, María Aguilar-Ballester, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3775-3775
Open Access | Times Cited: 3
Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 Diabetes
Jordan S. Carroll, Jessie Chen, Rahul Mittal, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1914-1914
Open Access
Page 1 - Next Page

Scroll to top